Coligand effects on the solution stability, biodistribution and metabolism of the 99mTc-labeled cyclic RGDfK tetramer
- 31 January 2008
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (1) , 111-121
- https://doi.org/10.1016/j.nucmedbio.2007.08.006
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptideNuclear Medicine and Biology, 2007
- 99mTc-Labeled Cyclic RGDfK Dimer: Initial Evaluation for SPECT Imaging of Glioma Integrin αvβ3 ExpressionBioconjugate Chemistry, 2006
- Two Technetium-99m-Labeled Cholecystokinin-8 (CCK8) Peptides for Scintigraphic Imaging of CCK ReceptorsBioconjugate Chemistry, 2004
- Micro-PET Imaging of αvβ3-Integrin Expression with 18F-Labeled Dimeric RGD PeptideMolecular Imaging, 2004
- Angiogenesis in GliomaThe Cancer Journal, 2003
- αvβ3 and αvβ5 Integrin Expression in Glioma PeripheryNeurosurgery, 2001
- Tc-99m-labeled small biomolecules as potential radiopharmaceuticals for infection and inflammation imagingDrugs of the Future, 2001
- Integrins as novel drug discovery targets: potential therapeutic and diagnostic implicationsEmerging Therapeutic Targets, 2000
- Effect of “co-ligand” on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptidesNuclear Medicine and Biology, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994